ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Non-Invasive Test May Detect Lung Cancer In Early Stages

September 26, 2003

FDA Orders More Changes In ESA Label,

August 8, 2008

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

DCPC Faces Huge Out Year Costs Of Four Trials

February 15, 1991

NCI to Study Vasectomy And Prostate Cancer: DCE Concepts OK’d

July 2, 1993

Reviewers Found For Chronobiolgy

June 30, 1989